Paying for Cures: A Radical Fix for Cell and Gene Therapies
A new proposal argues that without new payment models, cell and gene therapy innovation will stall.
Clinical AI, drug discovery, devices, and regulatory approvals.
A new proposal argues that without new payment models, cell and gene therapy innovation will stall.
Matthew Herper, who interviewed Elizabeth Holmes twice, argues Nathan Fielder's film lets her compelling but misleading style overshadow technical truths.
A nurse and cancer patient argues that AI-generated patient materials must be tested by patients themselves, not just checked for medical accuracy.
The approval gives postmenopausal women with an intact uterus a more affordable once-weekly option for managing hot flashes and preventing osteoporosis.
A new model from Mass General and Harvard researchers estimates that replacing the universal hepatitis B birth dose with later vaccination could increase chronic infections in children by up to 83%.
A STAT analysis finds OpenEvidence's new JAMA paper leaves key questions unanswered.
A new report finds hospital and health system M&A held steady in Q3, with 2026 potentially becoming a top year for deals since before the pandemic.
The Tel Aviv startup's PercStoma device could offer a less invasive option for bowel obstruction patients who are not candidates for traditional ostomy surgery.
A single-day roundup covers a major China-linked ADC deal, a second successful Phase 3 for an oral minoxidil, and several financing and regulatory updates.
Phentolamine eye drops offer a new topical option for age-related near vision loss, backed by phase III data.
A cluster randomized trial found agenda-setting cards improved clinician satisfaction but did not change HbA1c or illness intrusiveness for type 2 diabetes patients.
At 80, Trump's medical team keeps a doctor within three minutes of the president, yet public health disclosures have become less detailed, according to a Wall Street Journal report.
A systematic review of 16 million people found ADHD associated with increased risk of death from suicide, injury, and natural causes, while medication use correlated with lower mortality.
A new modeling study projects that replacing the universal birth dose with shared decision-making could increase chronic hepatitis B infections by 83% and leave millions more susceptible.
The PD-1 inhibitor dostarlimab won accelerated approval for a small rectal cancer subgroup, with most trial patients avoiding surgery for at least a year.
AdvaMed's chief executive used the MedTech Conference to lay out the industry's four main lobbying priorities for the coming year.
A technique derived from algae lets researchers switch brain cells on and off with light, and has already been used to activate memories.
New research suggests that modest daily walking is associated with less tau buildup and roughly half the cognitive and functional decline in at-risk individuals.